153 related articles for article (PubMed ID: 12614344)
21. Isoform-specific vasoconstriction induced by apolipoprotein E and modulation of this effect by Alzheimer's beta-amyloid peptide.
Paris D; Town T; Parker TA; Humphrey J; Mullan M
Neurosci Lett; 1998 Nov; 256(2):73-6. PubMed ID: 9853706
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein-E modulates the cytotoxic effect of beta-amyloid on rat brain endothelium in an isoform-dependent specific manner.
Folin M; Baiguera S; Guidolin D; Di Liddo R; Grandi C; De Carlo E; Nussdorfer GG; Parnigotto PP
Int J Mol Med; 2006 May; 17(5):821-6. PubMed ID: 16596266
[TBL] [Abstract][Full Text] [Related]
23. Interaction of nascent ApoE2, ApoE3, and ApoE4 isoforms expressed in mammalian cells with amyloid peptide beta (1-40). Relevance to Alzheimer's disease.
Aleshkov S; Abraham CR; Zannis VI
Biochemistry; 1997 Aug; 36(34):10571-80. PubMed ID: 9265639
[TBL] [Abstract][Full Text] [Related]
24. ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.
Manelli AM; Stine WB; Van Eldik LJ; LaDu MJ
J Mol Neurosci; 2004; 23(3):235-46. PubMed ID: 15181252
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
Willén K; Sroka A; Takahashi RH; Gouras GK
J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
[TBL] [Abstract][Full Text] [Related]
26. Beta-amyloid peptide interacts specifically with the carboxy-terminal domain of human apolipoprotein E: relevance to Alzheimer's disease.
Pillot T; Goethals M; Najib J; Labeur C; Lins L; Chambaz J; Brasseur R; Vandekerckhove J; Rosseneu M
J Neurochem; 1999 Jan; 72(1):230-7. PubMed ID: 9886074
[TBL] [Abstract][Full Text] [Related]
27. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein E modulates gamma-secretase cleavage of the amyloid precursor protein.
Irizarry MC; Deng A; Lleo A; Berezovska O; Von Arnim CA; Martin-Rehrmann M; Manelli A; LaDu MJ; Hyman BT; Rebeck GW
J Neurochem; 2004 Sep; 90(5):1132-43. PubMed ID: 15312168
[TBL] [Abstract][Full Text] [Related]
29. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
Lue LF; Kuo YM; Roher AE; Brachova L; Shen Y; Sue L; Beach T; Kurth JH; Rydel RE; Rogers J
Am J Pathol; 1999 Sep; 155(3):853-62. PubMed ID: 10487842
[TBL] [Abstract][Full Text] [Related]
30. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.
Hao J; Zhang W; Zhang P; Liu R; Liu L; Lei G; Su C; Miao J; Li Z
Neuropeptides; 2010 Aug; 44(4):305-13. PubMed ID: 20363024
[TBL] [Abstract][Full Text] [Related]
31. Contribution of cysteine 158, the glycosylation site threonine 194, the amino- and carboxy-terminal domains of apolipoprotein E in the binding to amyloid peptide beta (1-40).
Aleshkov SB; Li X; Lavrentiadou SN; Zannis VI
Biochemistry; 1999 Jul; 38(28):8918-25. PubMed ID: 10413465
[TBL] [Abstract][Full Text] [Related]
32. Beta-amyloid peptides increase the binding and internalization of apolipoprotein E to hippocampal neurons.
Beffert U; Aumont N; Dea D; Lussier-Cacan S; Davignon J; Poirier J
J Neurochem; 1998 Apr; 70(4):1458-66. PubMed ID: 9523562
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease beta-amyloid precursor protein.
Haas C; Cazorla P; Miguel CD; Valdivieso F; Vázquez J
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):169-75. PubMed ID: 9224643
[TBL] [Abstract][Full Text] [Related]
34. Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation.
Cho HS; Hyman BT; Greenberg SM; Rebeck GW
J Neuropathol Exp Neurol; 2001 Apr; 60(4):342-9. PubMed ID: 11305869
[TBL] [Abstract][Full Text] [Related]
35. A seed for Alzheimer amyloid in the brain.
Hayashi H; Kimura N; Yamaguchi H; Hasegawa K; Yokoseki T; Shibata M; Yamamoto N; Michikawa M; Yoshikawa Y; Terao K; Matsuzaki K; Lemere CA; Selkoe DJ; Naiki H; Yanagisawa K
J Neurosci; 2004 May; 24(20):4894-902. PubMed ID: 15152051
[TBL] [Abstract][Full Text] [Related]
36. ApoE promotes the proteolytic degradation of Abeta.
Jiang Q; Lee CY; Mandrekar S; Wilkinson B; Cramer P; Zelcer N; Mann K; Lamb B; Willson TM; Collins JL; Richardson JC; Smith JD; Comery TA; Riddell D; Holtzman DM; Tontonoz P; Landreth GE
Neuron; 2008 Jun; 58(5):681-93. PubMed ID: 18549781
[TBL] [Abstract][Full Text] [Related]
37. ApoE-isoform-dependent cellular uptake of amyloid-β is mediated by lipoprotein receptor LR11/SorLA.
Yajima R; Tokutake T; Koyama A; Kasuga K; Tezuka T; Nishizawa M; Ikeuchi T
Biochem Biophys Res Commun; 2015 Jan; 456(1):482-8. PubMed ID: 25482438
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X
Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein E Isoforms Differentially Regulate Alzheimer's Disease and Amyloid-β-Induced Inflammatory Response in vivo and in vitro.
Dorey E; Bamji-Mirza M; Najem D; Li Y; Liu H; Callaghan D; Walker D; Lue LF; Stanimirovic D; Zhang W
J Alzheimers Dis; 2017; 57(4):1265-1279. PubMed ID: 28372324
[TBL] [Abstract][Full Text] [Related]
40. A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade.
Dolev I; Michaelson DM
Proc Natl Acad Sci U S A; 2004 Sep; 101(38):13909-14. PubMed ID: 15365176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
